PUBLICATION DISSEMINATION RESEARCH

Brand Owner (click to sort) Address Description
CASCADIAN CASCADIAN THERAPEUTICS, INC. 2601 FOURTH AVENUE, SUITE 500 SEATTLE WA 98121 Publication and dissemination of research reports in the fields of pharmaceuticals, biologicals, cancer treatments, and clinical trials;Manufacturing services for others, namely, manufacture of pharmaceutical and biological preparations used in the diagnosis and treatment of cancer and pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer;Pharmaceutical and biological preparations used in the diagnosis and treatment of cancer; pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer;Research in the fields of pharmaceutical and biological preparations used in the diagnosis and treatment of cancer and pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer; providing medical and scientific research information in the fields of pharmaceuticals, biologicals, and clinical trials;
CASCADIAN THERAPEUTICS CASCADIAN THERAPEUTICS, INC. 2601 FOURTH AVENUE, SUITE 500 SEATTLE WA 98121 Publication and dissemination of research reports in the fields of pharmaceuticals, biologicals, cancer treatments, and clinical trials;Manufacturing services for others, namely, manufacture of pharmaceutical and biological preparations used in the diagnosis and treatment of cancer and pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer;Pharmaceutical and biological preparations used in the diagnosis and treatment of cancer; pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer;THERAPEUTICS;Research in the fields of pharmaceutical and biological preparations used in the diagnosis and treatment of cancer and pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer; providing medical and scientific research information in the fields of pharmaceuticals, biologicals, and clinical trials;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A system and method are disclosed for facilitating fast-forwarding by viewers through a first-run program beyond the current broadcast point. In one embodiment, the first-run program is distributed before its scheduled publication time, and may be viewed at any time after the publication time. In a second embodiment, content is distributed on or after the publication time, but at a rate greater than the normal viewing rate. In a third embodiment, content is distributed on demand after the publication time by a media distribution server. In a fourth embodiment, a viewer participating in a multicast session of the content requests content beyond the current broadcast point. The viewer is switched to a unicast session, and the requested content is transmitted to the viewer. In alternative embodiments, a release code may be provided to control the time after which the viewer will be permitted to view program segments beyond the current broadcast point.